SEARCH

SEARCH BY CITATION

References

  • 1
    Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., Ferrante, A. W., Jr, (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112: 17961808.
  • 2
    Clement, K., Viguerie, N., Poitou, C., et al (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 18: 16571669.
  • 3
    Cinti, S., Mitchell, G., Barbatelli, G., et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 46: 23472355.
  • 4
    Xu, H., Barnes, G. T., Yang, Q., et al (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 112: 18211830.
  • 5
    Trayhurn, P., Wood, IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 33: 10781081.
  • 6
    Bouloumie, A., Curat, C. A., Sengenes, C., Lolmede, K., Miranville, A., Busse, R. (2005) Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care. 8: 347354.
  • 7
    Uysal, K. T., Wiesbrock, S. M., Marino, M. W., Hotamisligil, GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389: 610614.
  • 8
    Yuan, M., Konstantopoulos, N., Lee, J., et al (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 293: 16731677.
  • 9
    Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P., Bahouth, SW (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 145: 22732282.
  • 10
    Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., Spiegelman, BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 95: 24092415.
  • 11
    Yudkin, JS (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 27 (Suppl 3), S25S28.
  • 12
    Steinberg, D., Vaughan, M., Nestel, P. J., Strand, O., Bergstroem, S. (1964) Effects of the prostaglandins on hormone-induced mobilization of free fatty acids. J Clin Invest. 43: 15331540.
  • 13
    Kather, H. (1981) Effects of prostaglandin E2 on adenylate cyclase activity and lipolysis in human adipose tissue. Int J Obes Relat Metab Disord. 5: 659663.
  • 14
    Richelsen, B. (1992) Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 47: 171182.
  • 15
    Chatzipanteli, K., Rudolph, S., Axelrod, L. (1992) Coordinate control of lipolysis by prostaglandin E2 and prostacyclin in rat adipose tissue. Diabetes. 41: 927935.
  • 16
    Richelsen, B., Pedersen, SB (1987) Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes. Endocrinology. 121: 12211226.
  • 17
    Richelsen, B., Pedersen, S. B., Moller-Pedersen, T., Bak, JF (1991) Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2. Metabolism. 40: 990996.
  • 18
    Kather, H. (1982) Inhibition of hormone-stimulated human fat cell-lipolysis by prostaglandin E2 and its synthetic analogue sulprostrone. Prostaglandins Leukot Med. 8: 525529.
  • 19
    Strong, P., Coleman, R. A., Humphrey, PP (1992) Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors. Prostaglandins. 43: 559566.
  • 20
    Tsuboi, H., Sugimoto, Y., Kainoh, T., Ichikawa, A. (2004) Prostanoid EP4 receptor is involved in suppression of 3T3–L1 adipocyte differentiation. Biochem Biophys Res Commun. 322: 10661072.
  • 21
    Funk, CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294: 18711875.
  • 22
    Smith, W. L., Garavito, R. M., DeWitt, DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and −2. J Biol Chem. 271: 3315733160.
  • 23
    Claveau, D., Sirinyan, M., Guay, J., et al (2003) Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model. J Immunol. 170: 47384744.
  • 24
    Trebino, C. E., Stock, J. L., Gibbons, C. P., et al (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A. 100: 90449049.
  • 25
    Narumiya, S., Sugimoto, Y., Ushikubi, F. (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev. 79: 11931226.
  • 26
    Jakobsson, P. J., Thoren, S., Morgenstern, R., Samuelsson, B. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A. 96: 72207225.
  • 27
    Ouellet, M., Falgueyret, J. P., Ear, P. H., et al (2002) Purification and characterization of recombinant microsomal prostaglandin E synthase-1. Protein Expr Purif. 26: 489495.
  • 28
    Tanikawa, N., Ohmiya, Y., Ohkubo, H., et al (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun. 291: 884889.
  • 29
    Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., Kudo, I. (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem. 275: 3277532782.
  • 30
    Murakami, M., Nakashima, K., Kamei, D., et al (2003) Cellular prostaglandin E2 production by membrane-bound prostaglan-din E synthase-2 via both cyclooxygenases-1 and −2. J Biol Chem. 278: 3793737947.
  • 31
    Fahmi, H. (2004) mPGES-1 as a novel target for arthritis. Curr Opin Rheumatol. 16: 623627.
  • 32
    Gaskins, H. R., Hausman, D. B., Martin, R. J., Hausman, GJ (1989) Evidence for abnormal prostaglandin synthesis in obese Zucker rat adipose cell cultures. J Nutr. 119: 458462.
  • 33
    Guay, J., Bateman, K., Gordon, R., Mancini, J., Riendeau, D. (2004) Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem. 279: 2486624872.
  • 34
    Boulet, L., Ouellet, M., Bateman, K. P., et al (2004) Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J Biol Chem. 279: 2322923237.
  • 35
    Soni, K. G., Lehner, R., Metalnikov, P., et al (2004) Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem. 279: 4068340689.
  • 36
    Buettner, R., Parhofer, K. G., Woenckhaus, M., et al (2006) Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 36: 485501.
  • 37
    Mancini, J. A., Blood, K., Guay, J., et al (2001) Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvantinduced arthritis. J Biol Chem. 276: 44694475.
  • 38
    Murakami, M., Naraba, H., Tanioka, T., et al (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem. 275: 3278332792.
  • 39
    Xie, Y., Kang, X., Ackerman, W. E., et al (2006) Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab. 8: 8393.
  • 40
    Thoren, S., Jakobsson, PJ (2000) Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur J Biochem. 267: 64286434.
  • 41
    Forsberg, L., Leeb, L., Thoren, S., Morgenstern, R., Jakobsson, P. (2000) Human glutathione dependent prostaglandin E synthase: gene structure and regulation. FEBS Lett. 471: 7882.
  • 42
    Ekstrom, L., Lyrenas, L., Jakobsson, P. J., Morgenstern, R., Kelner, MJ (2003) Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3. Biochim Biophys Acta. 1627: 7984.
  • 43
    Kubota, K., Kubota, T., Kamei, D., et al (2005) Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model. J Endocrinol. 187: 339345.
  • 44
    Shaw, J. E., Ramwell, PW (1968) Release of prostaglandin from rat epididymal fat pad on nervous and hormonal stimulation. J Biol Chem. 243: 14981503.
  • 45
    Illiano, G., Cuatrecasas, P. (1971) Endogenous prostaglandins modulate lipolytic processes in adipose tissue. Nat New Biol. 234: 7274.
  • 46
    Dalton, C., Hope, HR (1973) Inability of prostaglandin synthesis inhibitors to affect adipose tissue lipolysis. Prostaglandins. 4: 641651.
  • 47
    Fain, J. N., Psychoyos, S., Czernik, A. J., Frost, S., Cash, WD (1973) Indomethacin, lipolysis, and cyclic AMP accumulation in white fat cells. Endocrinology. 93: 632639.
  • 48
    Casimir, D. A., Miller, C. W., Ntambi, JM (1996) Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3–L1 cells. Differentiation. 60: 203210.
  • 49
    Gaillard, D., Negrel, R., Lagarde, M., Ailhaud, G. (1989) Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J. 257: 389397.
  • 50
    Negrel, R., Gaillard, D., Ailhaud, G. (1989) Prostacyclin as a potent effector of adipose-cell differentiation. Biochem J. 257: 399405.
  • 51
    Catalioto, R. M., Gaillard, D., Maclouf, J., Ailhaud, G., Negrel, R. (1991) Autocrine control of adipose cell differentiation by prostacyclin and PGF2 alpha. Biochim Biophys Acta. 1091: 364369.
  • 52
    Petersen, R. K., Jorgensen, C., Rustan, A. C., et al (2003) Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases. J Lipid Res. 44: 23202330.